Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications.
about
Transcatheter embolization therapy in liver cancer: an update of clinical evidencesHigh intensity focused ultrasound, liver disease and bridging therapyUpdate in management of hepatocellular carcinoma in Eastern populationHepatoma Rupture following Drug-Eluting Bead ChemoembolizationHigh-Intensity Focused Ultrasound: Current Status for Image-Guided TherapyBlock Copolymer Membranes for Efficient Capture of a Chemotherapy DrugAdvances in non-surgical management of primary liver cancer.Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence.Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.350-560 μm gelatin sponge particles combined with transcatheter arterial chemoembolization for the treatment of elderly hepatocellular carcinoma: The safety and efficacyEvaluation of CT vascularization patterns for survival prognosis in patients with hepatocellular carcinoma treated by conventional TACE.Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation.Embolization of liver tumors: Past, present and future.Transarterial embolization ablation of hepatocellular carcinoma with a lipiodol-ethanol mixture.Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies.Clinical evaluation of targeted arterial infusion of verapamil in the interventional chemotherapy of primary hepatocellular carcinoma.Predictors of repeat transarterial chemoembolization in the treatment of hepatocellular carcinomaTranscatheter arterial chemoembolization therapy for patients with unresectable hepatocellular carcinoma.Increased extrinsic apoptotic pathway activity in patients with hepatocellular carcinoma following transarterial embolization.Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocolPredictors of hepatic decompensation after TACE for hepatocellular carcinomaRadiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status.Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma.Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome.Radiotherapy and Sorafenib in the Management of Patients with Hepatocellular Carcinoma Have Led to Improved Survival: A Single Center Experience.Prognostic significance of miR-1268a expression and its beneficial effects for post-operative adjuvant transarterial chemoembolization in hepatocellular carcinomaStudy on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats.Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendationsThe promise of clinical interventions for hepatocellular carcinoma from the west to mainland China.Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety.Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: Consensus recommendations and review by an International Expert Panel.Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment.Polymeric nanoparticles as cancer-specific DNA delivery vectors to human hepatocellular carcinoma.miR-1285-3p acts as a potential tumor suppressor miRNA via downregulating JUN expression in hepatocellular carcinoma.Short-term imaging response after drug-eluting embolic trans-arterial chemoembolization delivered with the Surefire Infusion System® for the treatment of hepatocellular carcinoma.Survival prediction model for postoperative hepatocellular carcinoma patients.Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma.Anti-angiogenesis in hepatocellular carcinoma treatment: current evidence and future perspectives.Efficacy and safety of sorafenib in advanced hepatocellular carcinoma under daily practice conditions.
P2860
Q27003849-3AA2CF58-AB73-4CB3-86A4-3C707F9891E5Q27013241-77F165B7-D76B-4030-A407-FD94EA17EA28Q28080480-02976166-04EF-4D5A-8462-90E2CF21A0FBQ28083521-F7EC3613-74B9-443D-A62A-C834DC46C8A5Q28087298-B381A548-1BA5-4D3C-BE16-B2E9A36CD56DQ28597710-6516BC21-21EF-4333-94DE-D56C2A2AB2CAQ30423781-F0FA7ADC-4AA0-4D64-87AA-5BD6434FD3BFQ30458257-DE827085-E53C-414F-80BF-0A057B4F64B0Q30479629-5CBB6F1D-F79E-42E3-8465-B305F50E681DQ33606153-EA63C84C-1806-41B5-9AA2-2DEE358630D7Q33620645-3CE61933-1920-420A-8DE4-F6B2D2CEC75DQ33872467-96B586DE-C79F-464B-AC81-1136318623FEQ34302900-975CBD2E-AAF6-41BD-ACAF-35ED452E0EE9Q34385204-A7EADEBF-3B34-4388-BBBC-4387B33D5FD1Q34409128-89982774-05B3-44AA-A37C-D87CF05857E1Q34588085-DFC0D252-AEB8-4214-8C75-3832CD423A17Q34618735-BD405854-62E3-4845-BBBC-F1BB5F283684Q35085720-51830FB1-7418-4E82-B3CE-AEB41E4BB9D2Q35600929-A0B5BB7E-3DD9-4329-8FFA-0C91A3E97780Q36027056-BD67F9E9-87C4-4973-94F4-CE8ACA75F3B2Q36140437-1F13C83E-740A-401F-B3C2-A5D90CB0FFD3Q36390438-0CF24D12-3F82-4DDB-8F1D-E15669CC9936Q36821641-B6DC75FA-9498-42ED-90FF-50C9C6FE2B9DQ36962089-974489D0-51C9-44FE-BF19-3C52251CCABEQ37012028-04DB0F04-1530-4102-A11C-6A032C7287D5Q37379525-2457E0FD-900D-4C56-949B-A109FE1CA2E6Q37682471-4BA687F8-4944-4437-8596-A913BDDD586FQ37947148-5CF8F735-5EEC-47EC-A4C6-504CAC88D7D1Q38080596-678493B2-48A4-4D12-A61F-09A9E48D3A0BQ38160838-E220AF2E-3A98-4659-B769-55058E0D26F3Q38164112-4F37CC09-3EB6-442E-9124-2028F61356F0Q38185970-8B0933A4-EED6-419A-A9BF-B6878C1E0A94Q38815080-27D51D59-A5CC-414C-8857-C8862FC93950Q38870484-0C9EB974-2A54-4EC2-A4AD-8443E0D4C7F4Q38955621-0FCFB9A3-EB09-4594-96C9-920E515BE6C4Q41592391-D96DA5A1-6DAC-486A-BB11-C5F1CF6D93EFQ42360762-92366430-1BF5-4AE6-9E9C-4DED00D2FE0DQ42669016-99697C4F-8E7C-4BAB-A680-8E37AEAC2B80Q42871162-D14DDFD4-4F95-4AF4-AD88-5E23972783E4Q43010565-FDA5BDE0-4426-4A8F-A8B8-5E1832C05746
P2860
Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Review on transarterial chemoe ...... , and symptomatic indications.
@ast
Review on transarterial chemoe ...... , and symptomatic indications.
@en
type
label
Review on transarterial chemoe ...... , and symptomatic indications.
@ast
Review on transarterial chemoe ...... , and symptomatic indications.
@en
prefLabel
Review on transarterial chemoe ...... , and symptomatic indications.
@ast
Review on transarterial chemoe ...... , and symptomatic indications.
@en
P2093
P1476
Review on transarterial chemoe ...... , and symptomatic indications.
@en
P2093
Ahmed Abdelkader
Alborz Hedayati Emami
Mohamed Nabil
Nagy N N Naguib
Pramod Rao
Stefan Zangos
P304
P356
10.1016/J.EJRAD.2008.08.007
P577
2008-10-02T00:00:00Z